✦ LIBER ✦

Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)

✍ Scribed by Masato Ozaka; Yuji Matsumura; Hiroshi Ishii; Yasushi Omuro; Takao Itoi; Hisatsugu Mouri; Keiji Hanada; Yasutoshi Kimura; Iruru Maetani; Yoshinobu Okabe; Masaji Tani; Takaaki Ikeda; Susumu Hijioka; Ryouhei Watanabe; Shinya Ohoka; Yuki Hirose; Masafumi Suyama; Naoto Egawa; Atsushi Sofuni; Takaaki Ikari; Toshifusa Nakajima

Book ID: 113028054
Publisher: Springer
Year: 2012
Tongue: English
Weight: 406 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-012-1822-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized phase II study of gemcitabi

A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer

✍ Sasaki, Takashi; Isayama, Hiroyuki; Nakai, Yousuke; Ito, Yukiko; Yasuda, Ichiro; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 190 KB

A multicenter phase II study of gemcitab

A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer

✍ Do-Youn Oh; Yongjun Cha; In-Sil Choi; So-Young Yoon; In Keun Choi; Jee Hyun Kim; 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 352 KB

Phase II randomised proof-of-concept stu

Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer

✍ Heinemann, V; Ebert, M P; Laubender, R P; Bevan, P; Mala, C; Boeck, S 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 114 KB

6596 POSTER A Randomized Phase II Study

6596 POSTER A Randomized Phase II Study of Gemcitabine (GEM) Plus S-1 Combination Chemotherapy Versus GEM Monotherapy in Patients (pts) With Advanced Biliary Tract Cancer (BTC) – GS-COMBI Study

✍ Sasaki, T.; Isayama, H.; Ito, Y.; Yasuda, I.; Toda, N.; Hanada, K.; Matsubara, S 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

717 ORAL Gemcitabine (GEM) plus capecita

717 ORAL Gemcitabine (GEM) plus capecitabine (CAP) versus GEM alone in locally advanced or metastatic pancreatic cancer. aspects of quality of life in a randomized phase III study of the Swiss Group for Clinical Cancer Research (SAKK) and the Central European Cooperative Oncology Group (CECOG)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 261 KB

A phase II open-label randomized study t

A phase II open-label randomized study to assess the efficacy and safety of selumetinib (AZD6244 [ARRY-142886]) versus capecitabine in patients with advanced or metastatic pancreatic cancer who have failed first-line gemcitabine therapy

✍ György Bodoky, Constanta Timcheva, David Robert Spigel, Phillip Joseph La Stella 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 640 KB